Hong Kong-listed innovative drug stocks continue to rise, with CSPC Pharmaceutical Group up over 10%

NightAirdropper · 2026-03-27T19:28:07+00:00

Gelonghui March 27 | The Hong Kong stock market's innovative drug stocks continued to rise in the afternoon, with the following notable gains: Genting New Era up over 11%, CSPC Pharmaceutical Group up over 10%, Ascletis Pharma-B, Legend Biotech, Cinda Biologics up over 7%, Hansoh Pharmaceutical, Sino Biopharmaceutical, Innovent Biologics, Lepu Biopharma-B up over 6%, BeiGene, Rongchang Biotech, Kelun-Biotech, Otsuka Vision Biotech-B, Fosun Pharma up over 5%.

NightAirdropper

2026-03-27 19:28:07

Gelonghui March 27｜In the afternoon, the gains of Hong Kong stock market’s innovative drug stocks further widened. Among them, Yun Ding Xin Yao rose over 11%, CSPC Pharmaceutical Group increased over 10%, and stocks such as Sihuan Pharmaceutical-B, Innovent Biologics, and I-Mab rose over 7%. Hengrui Medicine, Sanyao Pharmaceutical, Nuocheng Jianhua, and Lepu Biotech-B rose over 6%, while BeiGene, Rongchang Biologics, Kelun-Biotech, OcuVUE Biotech-B, and Fosun Pharma increased over 5%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.